|
Product
|
I-TAC/CXCL11, Human
|
|
Cat#
|
101-27-172B
|
|
Sequence
|
FPMFKRGRCL CIGPGVKAVK VADIEKASIM YPSNNCDKIE
VIITLKENKG QRCLNPKSKQ ARLIIKKVER KNF
|
|
Unit/Weight
|
1 mg
|
|
Unit Price
|
$2093.00
|
|
Description
|
CXCL11 cDNA encodes a 94 amino acid (aa) residue precursor protein with a 21 aa residue putative signal sequence, which is cleaved to form the mature 73 aa residue protein. CXCL11 shares 36% and 37% amino acid sequence homology with IP-10 and MIG (two other known human non-ELR CXC chemokines), respectively. CXCL11 is expressed at low levels in normal tissues including thymus, spleen and pancreas. The expression of CXCL11 mRNA is radically up regulated in IFN-纬 and IL-1 stimulated astrocytes. Moderate increase in expression is also observed in stimulated monocytes. CXCL11 has potent chemoattractant activity for IL-2 activated T cells and transfected cell lines expressing CXCR3, but not freshly isolated T-cells, neutrophils or monocytes.
|
|
Molecular Weight
|
Approximately 8.3 kDa, a single non-glycosylated polypeptide chain containing 73 amino acids.
|
|
Purity
|
> 97 % by SDS-PAGE and HPLC analyses.
|
|
Storage
|
This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles.
|
|